Introduction
The regulation of myoblast dierentiation involves complex interactions between positive and negative eectors. Myogenic factors Myf5, MyoD, Myogenin and MRF4 appear to be positive eectors of major importance. These proteins belong to a bHLH transcription factors family, and activate transcription of genes speci®cally expressed in muscle tissue. In vivo experiments using disruption of genes encoding these myogenic factors in mice have led to the conclusion that whereas Myf5 and MyoD are more involved in cell commitment to the myogenic lineage, Myogenin plays a key role in induction of terminal dierentiation Rudnicki et al., 1992; Hasty et al., 1993; Nabeshima et al., 1993) .
A number of negative regulators of myoblast dierentiation have progressively been described, such as Id, Twist, ZEB, Mist1 or MyoR, acting principally by interfering with the transcriptional activity of myogenic factors (Benezra et al., 1990; Hebrok et al., 1997; Postigo and Dean, 1997; Lemercier et al., 1998; Lu et al., 1999) . Particular attention was also paid to cellular oncogenes, such as c-Src, c-Ras or c-Fos which prevent myoblast dierentiation by inhibiting myogenic factors expression and/or activity (Falcone et al., 1991; Lassar et al., 1989; Pedraza-Alva et al., 1994) . Amongst the oncogenes, since the initial study of Su et al. (1991) , c-Jun is also considered as a major myogenic repressor. However, the molecular basis of this in¯uence is not fully understood. In particular, it is well established that c-Jun activity involves cooperation with partners interacting in a range of AP-1 complexes including Fos-like and ATF2 proteins. The involvement of such cooperations in myogenesis regulation is suggested by previous studies indicating that stimulation of Fos-like and c-Jun proteins expression by Tetradecanoyl Phorbol Acetate (TPA) or okadaic acid fully abrogates myoblast dierentiation (Sulakhe et al., 1985; Park et al., 1992) . The interest in identi®cation of such c-Jun partners involved in this myogenic in¯uence has been strengthened by the observation that, depending on the nature of this cooperation, dierent genetic programs could be induced. In particular, studies concerning the in¯uence of c-Jun on chicken embryonic ®broblast transformation clearly established that anchorage-independent growth needs cooperation between c-Jun and Fos-like proteins, whereas serumindependent growth depends on a c-Jun/ATF2 co-operation Huguier et al., 1998; van Dam and Castellazzi, 2001) .
Taking all these bibliographic data into account, the major aim of this study was to identify the partners involved in the myogenic activity of c-Jun, using constitutive overexpression of c-Jun on the one hand, and/or c-Fos, Fra2 or ATF2 on the other, in avian myoblasts.
Results
Changes in c-Jun, c-Fos, Fra2 and ATF2 protein levels during avian myoblast differentiation This work was performed using the quail myoblast cell line QM7, established by Antin and Ordahl (1991) . This in vitro system reproduces all major in vivo events occurring during muscle dierentiation: myoblast proliferation, withdrawal from the cell cycle at cell con¯uence characterized by an early synthesis of postmitotic markers including connectin (Hill et al., 1986 ) and, after lowering serum level in the culture medium, terminal dierentiation characterized by myoblast fusion and expression of numerous muscle-speci®c proteins.
In an initial step, using Western blot experiments, we characterized our myogenic system by assessing the spontaneous changes occurring in the levels of c-Jun, cFos, Fra2 and ATF2 proteins during critical stages of QM7 myoblast dierentiation: proliferation, cell conuence and terminal dierentiation. Whereas c-Fos and Fra2 protein levels decreased at cell con¯uence and during dierentiation, the c-Jun level increased at cell con¯uence. No signi®cant change was detected for the ATF2 level (Figure 1 ). These data pointed out a possible involvement in myogenesis regulation of the rise in c-Jun expression occurring just before induction of terminal dierentiation. This led us to study the in¯uence of c-Jun overexpression on myoblast withdrawal from the cell cycle and on myotube formation.
Dual influence of c-Jun overexpression on avian myoblast differentiation
This study was performed by stably overexpressing wild-type c-Jun or a mutant deleted of the major part of the transactivation domain (c-Jun D176) in QM7 myoblasts. Control cells were obtained after cotransfection of pPD18 empty vector and pSV2-neo R plasmid, and selection of neomycine-resistant cells. Experiments were carried out on polyclonal populations of transfected cells. c-Jun and c-Jun D176 overexpression was assessed in Western blot experiments ( Figure 2 ).
Two sets of data were recorded. First, we studied myoblast withdrawal from the cell cycle at cell con¯uence, just before serum removal, by assessing the number of cells expressing connectin, a post-mitotic marker. Second, the extent of myoblast dierentiation was studied using morphological criteria in cytoimmuno¯uorescence experiments and calculation of the fusion index (FI).
At cell con¯uence, c-Jun overexpression signi®cantly decreased the number of cells expressing connectin, Figure 1 Changes in the expression of AP-1 family members during avian myoblast dierentiation. One hundred mg of proteins extracted from QM7 myoblasts during proliferation, at cell con¯uence or 72 h after the induction of dierentiation were analysed by Western blot using speci®c antibodies raised against avian c-Fos, Fra2, c-Jun and ATF2 proteins. Quanti®cation was performed using a phosphorimager (Molecular Dynamics). Results are expressed as percentages of the value recorded in proliferating myoblasts. Data are the mean+s.e.m. of four separate experiments. A typical Western blot is presented relative to control cultures (1.23+0.09% vs 2.99+0.31%, P50.01; Figure 3b ,a), thus indicating a signi®cant inhibition of myoblast withdrawal from the cell cycle. This in¯uence was not recorded after overexpression of the c-Jun D176 mutant (3.13+0.29%; Figure 3c ), thus establishing that the transactivation domain of the oncoprotein was directly involved in the repression of myoblast withdrawal from the cell cycle. These data establish a surprising dual myogenic activity of c-Jun, clearly dependent on the induction of dierentiation, at cell con¯uence. As we have previously shown that signi®cant changes in the relative amounts of dierent c-Jun partners occurred at this stage of the culture, we assessed the 
Opposite influences of Fos-like or ATF2 overexpression on c-Jun myogenic influence
To study the in¯uence of Fos-like or ATF2 cooperation with c-Jun on the myogenic in¯uence of the oncoprotein, we stably overexpressed c-Jun and/or ATF2, Fra2, c-Fos, in QM7 myoblasts (overexpression was assessed in Western blot experiments; Figure 2) . A TPA treatment, increasing c-Jun/c-Fos and c-Jun/Fra2 activity (Greenberg and Zi, 1984; Lamph et al., 1988; Yoshida et al., 1993) was also performed.
In cytoimmuno¯uorescence experiments, assessment of the number of connectin-expressing myoblasts at cell con¯uence, just before serum removal, led us to conclude that Fra2 or c-Fos overexpression inhibited QM7 myoblast withdrawal from the cell cycle relative to control myoblasts (respectively 1.18+0.11% and 1.13+0.25% vs 2.99+0.31%, P50.01; Figure 4d In agreement with previous data (Sulakhe et al., 1985) , we simultaneously observed that addition of TPA to the culture medium induced a potent block to myoblast withdrawal from the cell cycle (0.09+0.03%, P50.001; Figure 4f ). By contrast, co-expression of c-Jun and ATF2 increased the number of post-mitotic myoblasts relative to control cultures (4.50+0.42% vs 2.99+0.31%, P50.05; Figure 4g ) and some small myotubes were generally observed despite the presence of high serum concentration in the culture medium. All these results already suggest that the inhibition of myoblast withdrawal from the cell cycle induced by c-Jun was driven by cooperation with c-Fos or Fra2.
Furthermore, after serum removal, ATF2 or Fra2 overexpression did not signi®cantly in¯uence myoblast terminal dierentiation (control cells, FI: 16.46+1.29% vs 18.31+1.92% for ATF2 or 15.41+1.89% for Fra2; Figure This set of data strongly suggests that in avian myoblasts, c-Jun and ATF2 cooperate to stimulate terminal dierentiation, whereas cooperation between c-Jun and Fos-like proteins irreversibly inhibits withdrawal from the cell cycle and consequently terminal dierentiation.
Expression of myogenic factors is a target of AP-1 family members
In an attempt to determine the mechanisms involved in the dual myogenic activity of c-Jun, we studied the in¯uence of c-Jun and/or ATF2, Fra2, c-Fos stable Figure 6 In¯uence of expression or co-expression of AP-1 family members on myoD mRNA levels. Thirty mg of total RNAs isolated from control or overexpressing c-Jun and/or ATF2, Fra2 or c-Fos QM7 myoblasts, at cell con¯uence (A) and 48 h after the induction of dierentiation (B) were analysed by Northern blot. Quanti®cation was performed using a phosphorimager (Molecular Dynamics) and normalized in relation to S26 level. Results are expressed as percentages of the value recorded in control myoblasts. Data are the mean+s.e.m. of three separate experiments. A typical Northern blot is shown at each stage of the culture Figure 7 In¯uence of expression or co-expression of AP-1 family members on myogenin mRNA levels. Thirty mg of total RNAs isolated from control or overexpressing c-Jun and/or ATF2, Fra2 or c-Fos QM7 myoblasts, at cell con¯uence (A) and 48 h after induction of dierentiation (B) were analysed by Northern blot. Quanti®cation was performed using a phosphorimager (Molecular Dynamics) and normalized in relation to S26 level. Results are expressed as percentages of value recorded in control myoblasts. Data are the mean+s.e.m. of three separate experiments. A typical Northern blot is shown at each stage of the culture Oncogene Regulation of myoblast differentiation by c-Jun L Daury et al overexpression on the level of avian myoD and myogenin mRNAs in Northern blots experiments. At cell con¯uence, just before induction of dierentiation, no signi®cant in¯uence of c-Jun, ATF2 or cJun+ATF2 overexpression was detected on myoD mRNA levels ( Figure 6A ). However, Fra2, c-Jun+ Fra2, c-Fos and c-Jun+c-Fos signi®cantly decreased myoD mRNA levels (1.4-, 1.5-, 1.7-and 3-fold decrease respectively; Figure 6A ), as did a TPA treatment (threefold decrease). Similar data were obtained 48 h after serum removal, with the exception of Fra2 and c-Jun/Fra2 which did not exert their inhibitory in¯uence during dierentiation ( Figure 6B ).
As expected (Marchal et al., 1995) , myogenin mRNA levels were at the brink of detection at cell con¯uence and were up-regulated during terminal dierentiation. At cell con¯uence, ATF2 did not signi®cantly in¯uence myogenin mRNA levels, whereas c-Jun, Fra2 and c-Fos decreased these levels (1.7-, 2.3-and 2.2-fold decrease respectively; Figure 7A ); this reduction was even greater in c-Jun+Fra2 and cJun+c-Fos overexpressing myoblasts (4.2-and 3.2-fold decrease respectively; Figure 7A ), or in TPA-treated cells (®vefold decrease). By contrast, c-Jun+ATF2 moderately increased myogenin mRNA levels (1.4-fold increase; Figure 7A ). Forty-eight hours after induction of dierentiation, c-Jun overexpression signi®cantly increased myogenin mRNA levels (twofold increase; Figure 7B ) whereas c-Jun+ATF2 co-expression induced a fourfold increase. On the other hand, we found that c-Fos, and to a lesser extent Fra2, continued to inhibit myogenin mRNA levels (11-fold and twofold inhibition respectively; Figure 7B ). In addition, c-Jun+c-Fos and c-Jun+Fra2 inhibited myogenin mRNA levels more than c-Fos or Fra2 alone (16-fold and fourfold inhibition respectively; Figure 7B ). Moreover, a TPA treatment also greatly reduced myogenin expression (25-fold decrease; Figure  7B ).
All data concerning myogenic factors expression and dierentiation are summarized in Table 1 . Analysis of these results led to the conclusion that the in¯uence of all AP-1 family members on myoblast dierentiation was essentially related to their eect on myogenin mRNA levels (correlation between the fusion index and myogenin mRNAs, r=0.953, P50.001; correlation between the fusion index and myoD mRNAs, NS). In addition, the in¯uence of c-Fos on myoD expression has already been documented (Pedraza-Alva et al., 1994) , thus leading us to bring a particular attention to myogenin expression.
c-Jun/ATF2 cooperation activates myogenin promoter activity
In transient transfection experiments, we assessed the in¯uence of AP-1 family members on myogenin promoter activity. In agreement with data concerning myogenin mRNA levels, c-Jun expression induced a fourfold stimulation of the basal promoter activity (P50.005; Figure 8 ). Whereas devoid of any signi®cant in¯uence on myogenin promoter activity by themselves, c-Fos or Fra2 co-expression with c-Jun fully abrogated its transcriptional in¯uence (Figure 8) . Moreover, it appeared that c-Jun stimulation was potentiated by ATF2 co-expression (sevenfold stimulation relatively to basal activity, P50.001; twofold relatively to c-Juninduced activity; P50.01; Figure 8 ), despite the observation that ATF2 did not by itself in¯uence myogenin promoter activity. In addition, the c-Jun/ ATF2 cooperation was abrogated by c-Fos or Fra2 coexpression (Figure 8 ).
ATF2 functionality is required for the positive myogenic influence of c-Jun
In order to assess the requirement of ATF2 functionality for the stimulation of myoblast dierentiation by c-Jun, we studied the in¯uence of an ATF2 negative dominant mutant lacking the transactivation domain of the protein (ATF2 D276) on the ability of c-Jun to stimulate myogenin promoter activity and terminal dierentiation.
In transient transfection experiments, we established that ATF2 D276 expression greatly reduced Figure  9B ). Constitutive expression of this mutant in stably c-Jun overexpressing myoblasts fully repressed the ability of the oncoprotein to stimulate myoblast dierentiation (FI: 14.97+1.21% vs 15.43+1.01% for control cells, NS and vs 20.21+1.08% for c-Jun, P50.01; Figure 9b ). All these data indicate that ATF2 functionality is required for the positive c-Jun myogenic in¯uence.
The functional c-Jun/ATF2 interaction does not involve formation of an heterodimerical complex
To assess the possibility that stimulation of myogenin promoter activity was driven by formation of a c-Jun/ ATF2 heterodimerical complex, we studied the in¯uence of ATF2 coexpression with several c-Jun mutants : c-Jun eb1 only able to form homodimers, c-Jun m0 and c-Jun m1 displaying a preferential anity respectively for Foslike proteins, and ATF2 . Surprisingly, all c-Jun mutants stimulated myogenin promoter activity as wild-type c-Jun did (about threefold increase, P50.005, Figure 10 ). In addition, their in¯uence was similarly potentiated by ATF2 coexpression (5 ± 6-fold increase, P50.001). These data rule out the involvement of c-Jun Leucine Zipper in the cooperation with ATF2. In addition, they suggest that this cooperation does not involve formation of a c-Jun/ATF2 heterodimerical complex. In agreement with this possibility, in gel retardation experiments, we detected ATF2 binding to the minimal myogenin promoter sequence, but we failed to detect a signi®cant c-Jun binding (data not shown).
Discussion
Although it is generally assumed that c-Jun is a potent repressor of myoblast dierentiation, some aspects of this myogenic in¯uence remain unclear. In particular, identi®cation of partners possibly involved in this myogenic in¯uence is still lacking, leading us to characterize the c-Jun cooperations with proteins included in the diversity of AP-1 complexes. Unexpectedly, we found that, in relation to the nature of the cooperation, c-Jun exerts a dual in¯uence on myoblast dierentiation : repression through cooperation with Fos-like proteins, stimulation through cooperation with ATF2.
c-Jun exerts a dual myogenic influence
In this work, we observed that c-Jun stable overexpression exerts two opposite in¯uences on quail myoblast dierentiation, according to the stage of cell progression in the myogenic program. Whereas it represses myoblast withdrawal from the cell cycle before induction of dierentiation by reducing serum concentration in the culture medium, it signi®cantly stimulates myoblast terminal dierentiation after its induction. In the same line, a recent report indicates that c-Jun also exerts two opposite functions before and after neuronal dierentiation of PC12 cells (Leppa et al., 2001) . Whereas c-Jun expression protects undierentiated cells against apoptosis and triggers neurite formation, it induces apoptosis in dierentiated PC12 cells. In addition, the present study provides a set of convincing data indicating that this dual in¯uence in myoblasts is mediated through cooperation with dierent partners. Firstly, we established that the negative c-Jun myogenic in¯uence is linked to high endogenous levels of c-Fos or Fra2 proteins, whereas the positive eect is recorded after a spontaneous decrease in these levels, favoring c-Jun/ATF2 cooperation. Secondly, we observed that co-expression of c-Jun and c-Fos or Fra2 inhibits myoblast withdrawal from the cell cycle and terminal dierentiation, whereas coexpression of c-Jun and ATF2 exerts the opposite in¯uence. Therefore, these results clearly suggest that the repression of myoblast withdrawal from the cell cycle is induced by a c-Jun/Fos-like protein cooperation, in agreement with previous data indicating that TPA-inducible AP-1 activity is a potent repressor of myoblast dierentiation (Sulakhe et al., 1985) , also con®rmed in the present study. They also are in agreement with the work of Hirayama et al. (1995) reporting that TPA aects the step before commitment for fusion of quail myoblasts.
By contrast, the surprising stimulation of myoblast dierentiation by c-Jun overexpression recorded after serum removal appears to be driven by a c-Jun/ ATF2 cooperation. This possibility is well sustained by the observation that a negative dominant form of ATF2 not only abrogates the in¯uence of c-Jun on terminal dierentiation, but also inhibits by itself myoblast dierentiation. As ATF2 is devoid of any in¯uence by itself, these data suggest that ATF2 D276 exerts this negative in¯uence by abrogating the stimulation of terminal dierentiation by endogenous c-Jun, thus underlining the physiological relevance of this regulation.
The dual in¯uence of c-Jun reported in this study, related to the occurrence of changes in predominant cooperations with ATF2 or Fos-like proteins, has to be compared to results concerning its in¯uence on chicken embryonic ®broblast transformation. Whereas c-Jun/ Fos-like protein cooperation induces anchorage-independent cell growth, serum growth independency depends on a c-Jun/ATF2 cooperation (for review van Dam and Castellazzi, 2001) . Therefore, as in the present work, the nature of the c-Jun partner plays a crucial role in the induction of speci®c genetic programs.
Mechanisms involved in the c-Jun dual influence on myoblast differentiation
We searched for the in¯uence of c-Jun on myoD and myogenin expression, paying particular attention to the cooperations of the oncoprotein with ATF2 or Fos-like proteins. As myoD mRNA levels are not in¯uenced at any stage of the culture by c-Jun and/or ATF2 expression, we conclude that myoD expression is not a target for c-Jun/ATF2 cooperation. By contrast, cJun/c-Fos co-expression or a TPA treatment signi®-cantly reduces myoD expression, in agreement with previous data obtained in murine myoblasts (PedrazaAlva et al., 1994) .
We were particularly interested in the regulation of myogenin expression by c-Jun. We ®rst observed that, for each kind of expression or co-expression experiment, myogenin mRNA levels are highly signi®cantly related to the extent of myoblast fusion. In association with the major importance of myogenin for the induction of terminal dierentiation established in gene disruption experiments (Hasty et al., 1993; Nabeshima et al., 1993) , this observation suggests that this gene is an important target for c-Jun interactions. Interestingly, the stimulation of terminal dierentiation by c-Jun is associated with a rise in myogenin mRNA levels, and potentiated by ATF2 coexpression. In conjunction with the observations indicating that c-Jun increases myogenin promoter activity, and that this in¯uence is enhanced by ATF2 co-expression, this set of data leads us to conclude that c-Jun/ATF2 cooperation increases transcription of the myogenin gene, and consequently myoblast terminal dierentiation. Furthermore, this possibility is also supported by the observation that the c-Juninduced rise in myogenin promoter activity is abrogated by expression of an ATF2 negative dominant. This last result establishes that endogenous ATF2 functionality is required for the c-Jun stimulation of myogenin expression. However, the exact nature of the c-Jun/ATF2 cooperation remains to be established. The use of Leucine Zipper mutants of cJun suggests that such cooperation does not involve cJun/ATF2 heterodimer formation. This result is substantiated by EMSA experiments: we systematically observed a signi®cant binding of two ATF2-containing complexes to a sequence of the minimal myogenin promoter, but we have not, to date, detected c-Jun binding to DNA (data not shown).
Conversely, cooperation between c-Jun and Fos-like proteins results in a reduction in myogenin mRNA levels: (1) the inhibition of myogenin expression induced by c-Jun before serum removal is potentiated by Fra2 or c-Fos co-expression; (2) after the induction of myoblast dierentiation, co-expression of Fos-like proteins turns the stimulatory activity of c-Jun on myogenin expression into a repressive one. These data suggest that cooperation between c-Jun and Fos-like proteins are speci®cally involved in the reduction of myogenin mRNA levels. Study of myogenin promoter activity indicates that this regulation partly occurs at the transcriptional level. The observation that c-Fos and Fra2 do not by themselves in¯uence myogenin promoter activity, but abrogate the stimulation induced by c-Jun, clearly suggests an indirect in¯uence. In particular, as ATF2 cooperation is needed for the increase in myogenin expression induced by c-Jun, it could be put forward that overexpression of c-Fos or Fra2 competes eciently with ATF2 for cooperating with c-Jun.
Conclusions
In this work, we have provided evidence that c-Jun exerts a dual in¯uence on avian myoblast dierentiation. By acting through TPA-inducible interactions involving Fos-like proteins, c-Jun could prevent an anticipated myoblast dierentiation able to induce a de®ciency in muscle development. Thereafter, by acting through c-Jun/ATF2 cooperations at the onset of dierentiation, characterized by a decrease in the expression of c-Fos and Fra2, c-Jun stimulates terminal dierentiation, leading to an optimal muscle development. Such a mechanism is interesting because it demonstrates that the same transcription factor could exert two opposite in¯uences depending on the nature of its partner, however leading to a common developmental bene®t. It remains now to understand the mechanisms inducing the changes observed in the expression of c-Jun partners.
Materials and methods

Cell cultures
Quail myoblasts of the QM7 cell line (Antin and Ordahl, 1991) were seeded at a plating density of 7000 cells/cm 2 . They were grown in medium 199 supplemented with tryptose phosphate broth (0.2%), L-glutamin (2 mM), gentamicin (50 mg/ml), and fetal calf serum (10%). Terminal dierentiation was induced after 96 h of culture at cell con¯uence by lowering the medium's fetal calf serum concentration to 0.5%.
Plasmids and reporter genes
The pDP18 c-Jun, pDP18 ATF2, pDP18 c-Fos and pDP18 Fra2 expression vectors led to the expression of the corresponding quail proteins (Vial et al., 2000) . The pDP18 c-Jun D176 expression vector (Castellazzi et al., 1993) led to the expression of a c-Jun mutant deleted from almost all the transactivating domain. The pDP18 ATF2 D276 expression vector (Huguier and Castellazzi, unpublished data) led to the expression of an ATF2 mutant deleted from all the transactivating domain. The pDP18 c-Jun m1 and pDP18 c-Jun m0 expression vectors led to the expression of c-Jun mutants which preferentially heterodimerize with respectively ATF2 and Fos-like proteins. The pDP18 c-Jun eb1 expression vector (Castellazzi et al., 1993) led to the expression of a c-Jun mutant in which the natural dimerization domain was replaced by the dimerization domain of the viral EB1 protein (c-Jun eb1 only forms homodimers). The 7131/+40 avian myogenin-CAT reporter plasmid contains a fragment of the chicken minimal myogenin promoter upstream the CAT reporter gene (Malik et al., 1995) .
Stable transfections
Cells were transfected using the calcium phosphate coprecipitation method as previously described (Cassar-Malek et al., 1996) . QM7 myoblasts constitutively expressing c-Jun were obtained by co-transfection of 10 mg of pDP18 c-Jun expression vector with 2 mg of pSV2-neo R plasmid. Pools of stable clones were selected in medium containing Neomycin (G418, 500 mg/ml) for 12 days. Cells expressing c-Jun D176, ATF2, c-Fos and Fra2 were obtained with the same procedure using the corresponding plasmids previously mentioned.
Transient transfections and CAT assays
As for stable transfections, transient transfections were performed using the calcium phosphate co-precipitation procedure as previously described. One mg of pCMV bgalactosidase expression vector was cotransfected to provide an internal control of transfection eciency. After cell exposure to precipitates for 24 h, the DNA-containing medium was replaced with a fresh medium containing TPA (Tetradecanoyl Phorbol Acetate, 50 ng/ml) when indicated, and the cells were grown for a further 24 h. b-galactosidase activity was measured as previously described (Nielsen et al., 1983) . CAT enzymatic activity was measured by following the kinetics of chloramphenicol acetylation (Cassar-Malek et al., 1996) . Results are expressed as the percentage of control values after b-galactosidase normalization.
Cytoimmunofluorescence studies
Myoblast dierentiation was assessed by morphological changes and accumulation of connectin, a muscle speci®c marker only expressed in myoblast from withdrawal from the cell cycle (Hill et al., 1986) . After methanol ®xation and appropriate washings, cells were stained with an antibody raised against connectin (kindly provided by Dr F Pons, INSERM Montpellier, France) and a¯uorescein-conjugated antibody raised against mouse immunoglobulins. Myoblast withdrawal from the cell cycle was estimated by the per cent of cells expressing connectin at cell con¯uence (number of nuclei in stained myoblasts6100/total number of nuclei). To quantify terminal dierentiation, the fusion index (FI) was calculated by counting total nuclei and nuclei incorporated in myotubes (FI=number of nuclei in myotubes6100/total number of nuclei).
Protein preparation and Western blot analysis
One hundred mg of nuclear proteins were resolved by 10 or 12% SDS ± PAGE mini-gels and blotted onto nitrocellulose membranes that were further incubated with anti-c-Jun, antic-Fos, anti-Fra2 or anti-ATF2 polyclonal antibodies (Vial et al., 2000) . Signals were further detected by ECF (Amersham Pharmacia Biotech.). Quanti®cation was performed using a Storm was performed using a Storm phosphoimager (Molecular Dynamics).
RNA preparation and Northern blot analysis
Total RNAs were isolated after 96 h (cell con¯uence) and 144 h (terminal dierentiation) of culture, as described by Chomczynski and Sacchi (1987) . Thirty mg of total RNAs were loaded in each lane of 1% formaldehyde-agarose gel. After electrophoresis, RNAs were transferred onto nylon membrane. RNAs were hybridized with cDNA probes labeled with 32 P-adCTP using the Megaprime DNA labeling system (Amersham Pharmacia Biotech.). An S26 ribosomal protein cDNA probe was used to provide an invariant control as previously described (Vincent et al., 1993) . Quanti®cation was performed using a Storm phosphoimager (Molecular Dynamics).
Statistical analysis
Statistical analyses were performed using the paired t-test (Snedecor, 1961) .
